Update on the Cediranib and Sunitinib Clinical Trials for Alveolar Soft Part Sarcoma Phase II in the USA
Please note the two Phase II clinical trials available for ASPS patients in the US: 1. Sunitinib or Cediranib for Alveolar Soft Part Sarcoma, study number NCT01391962 Contact: NCI Referral Office, Tel. 1-888-NCI-1937 Locations: United States, California Santa Monica Oncology Center Santa Monica, California, United States, 90403 United States, Maryland National Institutes of Health […]